Professor Da-Yi Hu

来源 :老年心脏病学杂志:英文版 | 被引量 : 0次 | 上传用户:anlisha521
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Professor Da-Yi Hu (Figure 1) was born in Henan province of central China, in 1946.He graduated from the Beijing Medical School (now Peking University Health Science Center) in 1970 and furthered his education both at SUNY-Oswego and University of Illinoi
其他文献
在在照顾的弥漫的进展中在心血管的病态和死亡有重要衰落,包括经皮的 revascularization,机械循环支持,和 transcatheter 瓣膜的治疗。当进展治疗可以增加重要长寿时,他们也为必
The incidence of CIED(Cardiac Implantable Electronic Devices)infections is 0.13%–8.0%.[1,2]Fungal organisms account for up to 10%and Aspergillus infections are
The 30th of January 2012 was a sad day for thousands of Chinese cardiologists and geriatricians:they lost a respected and admired colleague,an outstanding leade
Objective To clarify whether cardiac cachexia(CC)alters the prognostic impact of other general risk factors in patients with heart failure(HF).Methods This was
1 Introduction Societies are ageing at an accelerated pace.This scenario is a well-known challenge for health care systems,as chronic diseases,multiple comorbid
Background In patients with acute ST-segment elevation myocardial infarction(STEMI)who undergo primary percutaneous coronary intervention(PCI),approximately 10%
Atrial fibrillation(AF)is a very common arrhythmia in clinical practice.Its incidence and prevalence are age-related and are growing in the last years.Age is a
A 67-year-old man with a history of a prior cardiac arrest with ventricular fibrillation(VF)due to myocardial infarction underwent phase I(inpatient)and II(outp
BackgroundThe 导致了 pluripotent 干细胞(iPSC ) 在心肌的梗塞(MI ) 的细胞的治疗显示出大潜力,当它的申请被 cardiomyocyte 区别的低效率妨碍时。现在的学习被设计从老鼠在